vs

Side-by-side financial comparison of Scilex Holding Co (SCLX) and TECHPRECISION CORP (TPCS). Click either name above to swap in a different company.

TECHPRECISION CORP is the larger business by last-quarter revenue ($7.1M vs $4.8M, roughly 1.5× Scilex Holding Co). TECHPRECISION CORP runs the higher net margin — -20.8% vs -961.9%, a 941.2% gap on every dollar of revenue. On growth, TECHPRECISION CORP posted the faster year-over-year revenue change (-6.9% vs -67.8%). Over the past eight quarters, TECHPRECISION CORP's revenue compounded faster (-9.2% CAGR vs -33.6%).

Scilex Holding Co is a commercial-stage biopharmaceutical firm focused on developing and commercializing innovative non-opioid pain management therapies for acute and chronic pain segments. It primarily serves the US market, offering prescription and over-the-counter pain relief solutions for patients and healthcare providers.

TechPrecision Corp is a manufacturer of custom high-precision metal fabricated components and integrated systems, serving aerospace, defense, medical technology, renewable energy, and industrial end markets primarily across North America and Europe. It specializes in producing tight-tolerance, mission-critical parts that adhere to rigorous industry quality requirements.

SCLX vs TPCS — Head-to-Head

Bigger by revenue
TPCS
TPCS
1.5× larger
TPCS
$7.1M
$4.8M
SCLX
Growing faster (revenue YoY)
TPCS
TPCS
+60.9% gap
TPCS
-6.9%
-67.8%
SCLX
Higher net margin
TPCS
TPCS
941.2% more per $
TPCS
-20.8%
-961.9%
SCLX
Faster 2-yr revenue CAGR
TPCS
TPCS
Annualised
TPCS
-9.2%
-33.6%
SCLX

Income Statement — Q4 FY2025 vs Q3 FY2026

Metric
SCLX
SCLX
TPCS
TPCS
Revenue
$4.8M
$7.1M
Net Profit
$-46.1M
$-1.5M
Gross Margin
45.5%
5.4%
Operating Margin
-2317.8%
-19.1%
Net Margin
-961.9%
-20.8%
Revenue YoY
-67.8%
-6.9%
Net Profit YoY
-613.7%
-84.4%
EPS (diluted)
$-4.63
$-0.15

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
SCLX
SCLX
TPCS
TPCS
Q4 25
$4.8M
$7.1M
Q3 25
$10.6M
$9.1M
Q2 25
$9.9M
$7.4M
Q1 25
$5.0M
$9.5M
Q4 24
$14.9M
$7.6M
Q3 24
$14.4M
$8.9M
Q2 24
$16.4M
$8.0M
Q1 24
$10.9M
$8.6M
Net Profit
SCLX
SCLX
TPCS
TPCS
Q4 25
$-46.1M
$-1.5M
Q3 25
$-257.8M
$825.0K
Q2 25
$-44.0M
$-597.0K
Q1 25
$-26.1M
$112.0K
Q4 24
$-6.5M
$-799.0K
Q3 24
$-4.4M
$-601.0K
Q2 24
$-37.6M
$-1.5M
Q1 24
$-24.4M
$-5.1M
Gross Margin
SCLX
SCLX
TPCS
TPCS
Q4 25
45.5%
5.4%
Q3 25
68.5%
27.1%
Q2 25
66.9%
14.0%
Q1 25
72.3%
22.0%
Q4 24
68.5%
13.0%
Q3 24
73.9%
11.3%
Q2 24
73.2%
3.0%
Q1 24
64.7%
14.3%
Operating Margin
SCLX
SCLX
TPCS
TPCS
Q4 25
-2317.8%
-19.1%
Q3 25
-1766.2%
10.4%
Q2 25
-207.2%
-6.3%
Q1 25
-557.5%
3.9%
Q4 24
-190.5%
-9.1%
Q3 24
-138.0%
-5.5%
Q2 24
-95.4%
-16.8%
Q1 24
-179.0%
-28.6%
Net Margin
SCLX
SCLX
TPCS
TPCS
Q4 25
-961.9%
-20.8%
Q3 25
-2441.5%
9.1%
Q2 25
-445.1%
-8.1%
Q1 25
-521.2%
1.2%
Q4 24
-43.4%
-10.5%
Q3 24
-30.4%
-6.7%
Q2 24
-229.6%
-18.3%
Q1 24
-224.0%
-59.5%
EPS (diluted)
SCLX
SCLX
TPCS
TPCS
Q4 25
$-4.63
$-0.15
Q3 25
$-22.17
$0.08
Q2 25
$-7.42
$-0.06
Q1 25
$-2.26
$0.01
Q4 24
$8.53
$-0.08
Q3 24
$-0.58
$-0.06
Q2 24
$-7.67
$-0.16
Q1 24
$-8.33
$-0.59

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
SCLX
SCLX
TPCS
TPCS
Cash + ST InvestmentsLiquidity on hand
$5.0M
$50.0K
Total DebtLower is stronger
Stockholders' EquityBook value
$-207.8M
$8.0M
Total Assets
$365.0M
$32.8M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
SCLX
SCLX
TPCS
TPCS
Q4 25
$5.0M
$50.0K
Q3 25
$878.0K
$220.0K
Q2 25
$4.1M
$143.0K
Q1 25
$5.8M
$195.0K
Q4 24
$3.3M
$165.0K
Q3 24
$77.0K
$132.0K
Q2 24
$6.9M
$44.8K
Q1 24
$1.8M
$138.0K
Total Debt
SCLX
SCLX
TPCS
TPCS
Q4 25
Q3 25
Q2 25
Q1 25
$3.0K
Q4 24
$19.0K
Q3 24
Q2 24
Q1 24
Stockholders' Equity
SCLX
SCLX
TPCS
TPCS
Q4 25
$-207.8M
$8.0M
Q3 25
$-176.9M
$9.1M
Q2 25
$-249.0M
$8.2M
Q1 25
$-211.5M
$8.7M
Q4 24
$-192.6M
$8.1M
Q3 24
$-211.3M
$8.9M
Q2 24
$-214.7M
$7.9M
Q1 24
$-189.8M
$7.8M
Total Assets
SCLX
SCLX
TPCS
TPCS
Q4 25
$365.0M
$32.8M
Q3 25
$275.9M
$33.8M
Q2 25
$83.8M
$32.1M
Q1 25
$79.0M
$33.5M
Q4 24
$93.0M
$32.2M
Q3 24
$100.4M
$35.0M
Q2 24
$104.5M
$35.7M
Q1 24
$91.2M
$34.7M
Debt / Equity
SCLX
SCLX
TPCS
TPCS
Q4 25
Q3 25
Q2 25
Q1 25
0.00×
Q4 24
0.00×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
SCLX
SCLX
TPCS
TPCS
Operating Cash FlowLast quarter
$-17.5M
$183.0K
Free Cash FlowOCF − Capex
$-827.0K
FCF MarginFCF / Revenue
-11.7%
Capex IntensityCapex / Revenue
14.2%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-4.4M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
SCLX
SCLX
TPCS
TPCS
Q4 25
$-17.5M
$183.0K
Q3 25
$8.2M
$-1.1M
Q2 25
$7.0M
$646.0K
Q1 25
$6.0M
$396.0K
Q4 24
$2.5M
$-570.0K
Q3 24
$5.1M
$-532.0K
Q2 24
$2.3M
$107.0K
Q1 24
$9.4M
$-452.0K
Free Cash Flow
SCLX
SCLX
TPCS
TPCS
Q4 25
$-827.0K
Q3 25
$-2.1M
Q2 25
$-604.0K
Q1 25
$-930.0K
Q4 24
$-1.7M
Q3 24
$-2.0M
Q2 24
$-94.0K
Q1 24
$-900.0K
FCF Margin
SCLX
SCLX
TPCS
TPCS
Q4 25
-11.7%
Q3 25
-22.9%
Q2 25
-8.2%
Q1 25
-9.8%
Q4 24
-22.9%
Q3 24
-21.8%
Q2 24
-1.2%
Q1 24
-10.5%
Capex Intensity
SCLX
SCLX
TPCS
TPCS
Q4 25
14.2%
Q3 25
11.0%
Q2 25
16.9%
Q1 25
14.0%
Q4 24
15.4%
Q3 24
0.0%
15.9%
Q2 24
2.5%
Q1 24
5.2%
Cash Conversion
SCLX
SCLX
TPCS
TPCS
Q4 25
Q3 25
-1.31×
Q2 25
Q1 25
3.54×
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

SCLX
SCLX

Segment breakdown not available.

TPCS
TPCS

Defense$6.7M94%
Other$410.0K6%

Related Comparisons